Literature DB >> 33625998

Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration.

Xiaoni Kou1, Jiang Zhu2, Xinke Xie3, Mingxia Hao3, Yingren Zhao4.   

Abstract

BACKGROUND/AIMS: This study aimed to explore the expression of long non-coding RNA MSC-AS1 in hepatocellular carcinoma (HCC) cells and its effect on the proliferation, migration, and apoptosis of HCC cells.
MATERIALS AND METHODS: The expression of MSC-AS1 in HCC cell lines BEL7402, SMMC7721, Huh7, HepG2, MHCC97-H, and normal hepatocyte line L02 was detected by reverse transcriptase polymerase chain reaction. The HCC cells were divided into blank, negative control (NC)-small interfering RNA (siRNA) (transfected with negative siRNA), and MSC-AS1 siRNA (transfected with MSC-AS1 siRNA) groups. Cell counting kit-8 and colony formation assays were used to determine the proliferation, and cell apoptosis, migration, and invasion were detected by flow cytometry, wound healing, and transwell assays, respectively. Western blot was used to detect the expression of related proteins.
RESULTS: The expression of MSC-AS1 in HCC cell lines was significantly higher than that in L02. In the MSC-AS1 siRNA group, the proliferation and colony formation of HCC cells were inhibited, whereas the apoptosis rate was significantly higher than that in the blank and NC-siRNA groups. The rate of wound healing and the number of invasion cells in the MSC-AS1 siRNA group were significantly lower than that in the blank and NC-siRNA groups.
CONCLUSION: MSC-AS1 was upregulated in HCC cells, and the downregulation of MSC-AS1 could inhibit cell proliferation, migration, and invasion and promote apoptosis of HCC cells.

Entities:  

Year:  2020        PMID: 33625998      PMCID: PMC7928261          DOI: 10.5152/tjg.2020.19485

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  22 in total

1.  Proliferation markers Ki67 and PCNA in cutaneous squamous cell carcinomas: lack of prognostic value.

Authors:  J Kanitakis; D Narvaez; S Euvrard; M Faure; A Claudy
Journal:  Br J Dermatol       Date:  1997-04       Impact factor: 9.302

2.  HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.

Authors:  Jun Li; Xiaochen Wang; Junwei Tang; Runqiu Jiang; Wenjie Zhang; Jie Ji; Beicheng Sun
Journal:  Cell Physiol Biochem       Date:  2015-09-11

3.  The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.

Authors:  Yunpeng Sun; Pengfei Wang; Wenjun Yang; Yunfeng Shan; Qiyu Zhang; Huanhuan Wu
Journal:  Cancer Biol Ther       Date:  2019-03-27       Impact factor: 4.742

4.  EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database.

Authors:  Zonglin Zhang; Surong Wang; Wenqi Liu
Journal:  Biochem Biophys Res Commun       Date:  2018-07-20       Impact factor: 3.575

Review 5.  Functional Classification and Experimental Dissection of Long Noncoding RNAs.

Authors:  Florian Kopp; Joshua T Mendell
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

6.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

7.  Hepatocellular carcinoma: focus on different aspects of management.

Authors:  Sene Waly Raphael; Zhang Yangde; Chen Yuxiang
Journal:  ISRN Oncol       Date:  2012-05-13

Review 8.  Management of centrally located hepatocellular carcinoma: Update 2016.

Authors:  Wei-Bo Yu; Andrew Rao; Victor Vu; Lily Xu; Jian-Yu Rao; Jian-Xiong Wu
Journal:  World J Hepatol       Date:  2017-05-08

9.  Identification of LINC01279 as a cell cycle‑associated long non‑coding RNA in endometriosis with GBA analysis.

Authors:  Jie Liu; Qi Wang; Rongrong Zhang; Chu Zhang; Jihui Lin; Xiaojie Huang
Journal:  Mol Med Rep       Date:  2018-08-14       Impact factor: 2.952

10.  LncRNA HOXA11-AS promotes hepatocellular carcinoma progression by repressing miR-214-3p.

Authors:  Meixiao Zhan; Ke He; Jing Xiao; Fei Liu; Haihe Wang; Zhenglin Xia; Xiaopeng Duan; Rui Huang; Yong Li; Xu He; Hua Yin; Guoan Xiang; Ligong Lu
Journal:  J Cell Mol Med       Date:  2018-05-15       Impact factor: 5.295

View more
  1 in total

1.  Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.

Authors:  Zi-An Chen; Hui Tian; Dong-Mei Yao; Yuan Zhang; Zhi-Jie Feng; Chuan-Jie Yang
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.